The Oncosearch | Oncotarget

Retraction: Long non-coding RNA HOTAIR acts as a competing endogenous RNA to promote malignant melanoma progression by sponging miR-152-3p Retraction

Wenkang Luan, Rubo Li, Liang Liu, Xin Ni, Yan Shi, Yun Xia, Jinlong Wang, Feng Lu, Bin Xu

Published Dec 24, 2025 · Vol. 16, No. 1 · pp. 892-892

Cigarette smoke and decreased DNA repair by Xeroderma Pigmentosum Group C use a double hit mechanism for epithelial cell lung carcinogenesis Research Paper

Nawar Al Nasrallah, Bowa Lee, Benjamin M. Wiese, Marie N. Karam, Elizabeth A. Mickler, Huaxin Zhou, Nicki Paolelli, Robert S. Stearman, Mark W. Geraci, Catherine R. Sears

Published May 9, 2025 · Vol. 16, No. 1 · pp. 396-409

Keywords: DNA repair, DNA damage, lung adenocarcinoma, squamous cell carcinoma, Xeroderma Pigmentosum Group C (XPC)

PD-L1 and FOXP3 expression in high-grade squamous intraepithelial lesions of the anogenital region Research Paper

Humberto Carvalho Carneiro, Rodrigo de Andrade Natal, José Vassallo, Fernando Augusto Soares

Published Apr 21, 2025 · Vol. 16, No. 1 · pp. 277-290

Keywords: HPV, high-grade intraepithelial lesion, immune evasion, PD-L1, FOXP3

Correction: Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells Correction

Mikaella Vouri, Qian An, Matthew Birt, Geoffrey J. Pilkington, Sassan Hafizi

Published Apr 4, 2025 · Vol. 16, No. 1 · pp. 260-261

Complete response to encorafenib plus binimetinib in a BRAF V600E-mutant metastasic malignant glomus tumor Case Report

Marta Arregui, Antonio Calles, María del Mar Galera, Ana Gutiérrez, Carlos López-Jiménez, Carolina Agra, Adriana Fernández, Natalia Gutiérrez, María de Toro, Rosa Álvarez

Published Sep 23, 2024 · Vol. 15, No. 1 · pp. 717-724

Keywords: malignant glomus tumor, glomangiosarcoma, BRAF V600E, agnostic treatment, targeted therapy

Linking FOXM1 and PD-L1 to CDK4/6-MEK targeted therapy resistance in malignant peripheral nerve sheath tumors Mini-Review

Joshua J. Lingo, Ellen Voigt, Dawn E. Quelle

Published Sep 19, 2024 · Vol. 15, No. 1 · pp. 638-643

Keywords: MPNST, FOXM1, PD-L1, CDK4/6-MEK targeting, therapy resistance

Comparison of FDG-PET/CT and CT for evaluation of tumor response to nivolumab plus ipilimumab combination therapy and prognosis prediction in patients with unresectable malignant pleural mesothelioma Research Paper

Kazuhiro Kitajima, Kozo Kuribayashi, Toshiyuki Minami, Hiroyuki Yokoyama, Akifumi Nakamura, Masaki Hashimoto, Takashi Kijima, Seiki Hasegawa, Hayato Kaida, Koichiro Yamakado

Published Jun 11, 2024 · Vol. 15, No. 1 · pp. 408-417

Keywords: mesothelioma, immunotherapy, FDG (fluorodeoxyglucose), PET-CT (positron emission tomography-computed tomography), immunotherapy-modified PERCIST (positron emission tomography response criteria in solid tumors)

Retraction: Knockdown of NEAT1 restrained the malignant progression of glioma stem cells by activating microRNA let-7e Retraction

Wei Gong, Jian Zheng, Xiaobai Liu, Jun Ma, Yunhui Liu, Yixue Xue

Published Mar 7, 2024 · Vol. 15, No. 1 · pp. 255-255

GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells Research Paper

Michael R. Booth, Laurence Booth, Jane L. Roberts, Cameron West, Paul Dent

Published Jan 29, 2024 · Vol. 15, No. 1 · pp. 124-133

Keywords: autophagy, ER stress, GZ17-6.02, bexarotene, vorinostat

BCAS1 defines a heterogeneous cell population in diffuse gliomas Research Paper

Raquel Morales-Gallel, María José Ulloa-Navas, Patricia García-Tárraga, Ricardo Prat-Acín, Gaspar Reynés, Pedro Pérez-Borredá, Luis Rubio, Vivian Capilla-González, Jaime Ferrer-Lozano, José Manuel García-Verdugo

Published Jan 10, 2024 · Vol. 15, No. 1 · pp. 49-64

Keywords: brain tumor, diffuse glioma, oligodendroglioma, glioblastoma, BCAS1

Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma Research Perspective

Bilal M. El-Masri, Benedeta Leka, Fatima Mustapha, Michael Tveden Gundesen, Maja Hinge, Thomas Lund, Thomas L. Andersen, Marta Diaz-delCastillo, Abbas Jafari

Published Jan 2, 2024 · Vol. 15, No. 1 · pp. 20-26

Keywords: multiple myeloma, MGUS, bone marrow adipocyte

The pharmacodynamic and mechanistic foundation for the antineoplastic effects of GFH009, a potent and highly selective CDK9 inhibitor for the treatment of hematologic malignancies Research Paper

Fusheng Zhou, Lili Tang, Siyuan Le, Mei Ge, Dragan Cicic, Fubo Xie, Jinmin Ren, Jiong Lan, Qiang Lu

Published Dec 9, 2023 · Vol. 14, No. 1 · pp. 997-1008

Keywords: GFH009, CDK9, cancer, leukemia, cell cycle

ACSL4: biomarker, mediator and target in quadruple negative breast cancer Review

Marie E. Monaco

Published Jun 5, 2023 · Vol. 14, No. 1 · pp. 563-575

Keywords: ACSL4, breast cancer, ferroptosis, molecular subtype, quadruple negative breast cancer

From the groin to the brain: a transfemoral path to blood-brain barrier opening Editorial

Thomas C. Chen, Weijun Wang, Axel H. Schönthal

Published Apr 18, 2023 · Vol. 14, No. 1 · pp. 413-416

Keywords: brain metastases, glioma, NEO100, perillyl alcohol, transfemoral cannulation

To be or not to be: the role of CD56 in multiple myeloma Editorial

Francesca Cottini, Don Benson

Published Jan 18, 2023 · Vol. 14, No. 1 · pp. 47-49

Keywords: myeloma, targeted therapies, CD56, signaling

Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more Review

Masahiko Shibata, Kotaro Nanno, Daigo Yoshimori, Takahiro Nakajima, Makoto Takada, Takashi Yazawa, Kousaku Mimura, Norio Inoue, Takafumi Watanabe, Kazunoshin Tachibana, Satoshi Muto, Tomoyuki Momma, Yoshiyuki Suzuki, Koji Kono, Shungo Endo, Seiichi Takenoshita

Published Oct 25, 2022 · Vol. 13, No. 1 · pp. 1273-1285

Keywords: MDSC, immunosuppression, Treg, TAM, cancer

Kinase activity profiling in renal cell carcinoma, benign renal tissue and in response to four different tyrosine kinase inhibitors Research Paper

Andliena Tahiri, Katarina Puco, Faris Naji, Vessela N. Kristensen, Glenny Cecilie Alfsen, Lorant Farkas, Frode S. Nilsen, Stig Müller, Jan Oldenburg, Jürgen Geisler

Published Jul 8, 2022 · Vol. 13, No. 1 · pp. 970-981

Keywords: kidney cancer, kinase activity, tyrosine kinase inhibitors, renal cell carcinoma, tyrosine kinase

Deciphering miR-520c-3p as a probable target for immunometabolism in non-small cell lung cancer using systems biology approach Research Paper

Pooja Gulhane, Prajakta Nimsarkar, Komal Kharat, Shailza Singh

Published May 7, 2022 · Vol. 13, No. 1 · pp. 725-746

Keywords: non-small cell lung cancer, miRNAs, miR-520c-3p, PI3K/AKT signaling pathway, therapeutic targeting

Altered glycosylation of several metastasis-associated glycoproteins with terminal GalNAc defines the highly invasive cancer cell phenotype Research Paper

Elham Khosrowabadi, Tomasz Wenta, Salla Keskitalo, Aki Manninen, Sakari Kellokumpu

Published Dec 22, 2021 · Vol. 13, No. 1 · pp. 73-89

Keywords: cancer, invasion, glycosylation, glycocode, terminal GalNAc, Helix Pomatia agglutinin (HPA)

TAK1-inhibitors are cytotoxic for multiple myeloma cells alone and in combination with melphalan Research Paper

Erling Håland, Ingrid Nyhus Moen, Elias Veidal, Hanne Hella, Kristine Misund, Tobias S. Slørdahl, Kristian K. Starheim

Published Sep 4, 2021 · Vol. 12, No. 21 · pp. 2158-2168

Keywords: multiple myeloma, TAK1, apoptosis, NF-κB, cancer treatment

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Retraction: Long non-coding RNA HOTAIR acts as a competing endogenous RNA to promote malignant melanoma progression by sponging miR-152-3p Retraction

Cigarette smoke and decreased DNA repair by Xeroderma Pigmentosum Group C use a double hit mechanism for epithelial cell lung carcinogenesis Research Paper

PD-L1 and FOXP3 expression in high-grade squamous intraepithelial lesions of the anogenital region Research Paper

Correction: Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells Correction

Complete response to encorafenib plus binimetinib in a BRAF V600E-mutant metastasic malignant glomus tumor Case Report

Linking FOXM1 and PD-L1 to CDK4/6-MEK targeted therapy resistance in malignant peripheral nerve sheath tumors Mini-Review

Comparison of FDG-PET/CT and CT for evaluation of tumor response to nivolumab plus ipilimumab combination therapy and prognosis prediction in patients with unresectable malignant pleural mesothelioma Research Paper

Retraction: Knockdown of NEAT1 restrained the malignant progression of glioma stem cells by activating microRNA let-7e Retraction

GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells Research Paper

BCAS1 defines a heterogeneous cell population in diffuse gliomas Research Paper

Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma Research Perspective

The pharmacodynamic and mechanistic foundation for the antineoplastic effects of GFH009, a potent and highly selective CDK9 inhibitor for the treatment of hematologic malignancies Research Paper

ACSL4: biomarker, mediator and target in quadruple negative breast cancer Review

From the groin to the brain: a transfemoral path to blood-brain barrier opening Editorial

To be or not to be: the role of CD56 in multiple myeloma Editorial

Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more Review

Kinase activity profiling in renal cell carcinoma, benign renal tissue and in response to four different tyrosine kinase inhibitors Research Paper

Deciphering miR-520c-3p as a probable target for immunometabolism in non-small cell lung cancer using systems biology approach Research Paper

Altered glycosylation of several metastasis-associated glycoproteins with terminal GalNAc defines the highly invasive cancer cell phenotype Research Paper

TAK1-inhibitors are cytotoxic for multiple myeloma cells alone and in combination with melphalan Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Retraction: Long non-coding RNA HOTAIR acts as a competing endogenous RNA to promote malignant melanoma progression by sponging miR-152-3p Retraction

Cigarette smoke and decreased DNA repair by Xeroderma Pigmentosum Group C use a double hit mechanism for epithelial cell lung carcinogenesis Research Paper

PD-L1 and FOXP3 expression in high-grade squamous intraepithelial lesions of the anogenital region Research Paper

Correction: Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells Correction

Complete response to encorafenib plus binimetinib in a BRAF V600E-mutant metastasic malignant glomus tumor Case Report

Linking FOXM1 and PD-L1 to CDK4/6-MEK targeted therapy resistance in malignant peripheral nerve sheath tumors Mini-Review

Comparison of FDG-PET/CT and CT for evaluation of tumor response to nivolumab plus ipilimumab combination therapy and prognosis prediction in patients with unresectable malignant pleural mesothelioma Research Paper

Retraction: Knockdown of NEAT1 restrained the malignant progression of glioma stem cells by activating microRNA let-7e Retraction

GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells Research Paper

BCAS1 defines a heterogeneous cell population in diffuse gliomas Research Paper

Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma Research Perspective

The pharmacodynamic and mechanistic foundation for the antineoplastic effects of GFH009, a potent and highly selective CDK9 inhibitor for the treatment of hematologic malignancies Research Paper

ACSL4: biomarker, mediator and target in quadruple negative breast cancer Review

From the groin to the brain: a transfemoral path to blood-brain barrier opening Editorial

To be or not to be: the role of CD56 in multiple myeloma Editorial

Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more Review

Kinase activity profiling in renal cell carcinoma, benign renal tissue and in response to four different tyrosine kinase inhibitors Research Paper

Deciphering miR-520c-3p as a probable target for immunometabolism in non-small cell lung cancer using systems biology approach Research Paper

Altered glycosylation of several metastasis-associated glycoproteins with terminal GalNAc defines the highly invasive cancer cell phenotype Research Paper

TAK1-inhibitors are cytotoxic for multiple myeloma cells alone and in combination with melphalan Research Paper